Crotonoside induces ferroptosis and mitochondrial dysfunction in AML

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Crotonoside, a guanine isomer, shows inhibitory effects on acute myeloid leukemia (AML) cell lines.
• The precise mechanisms of crotonoside's anti-leukemic activity are not fully understood.
• Previous studies suggest crotonoside's mechanism is not singular, prompting further investigation.

Purpose of the Study:

• To investigate the impact of crotonoside on mitochondrial function in AML cells.
• To determine if crotonoside induces ferroptosis in AML cells.
• To elucidate the molecular pathways involved in crotonoside-induced cell death.

Main Methods:

• Assessment of mitochondrial respiration, membrane potential, and mass in KG-1a and Molm-13 cell lines.
• Measurement of ferroptosis-related parameters.
• Molecular docking simulations to identify potential molecular targets.
• Analysis of the p62/KEAP1 signaling pathway and autophagy modulation.

Main Results:

• Crotonoside induces mitochondrial damage, leading to dysfunction and increased reactive oxygen species (ROS) production.
• The observed mitochondrial damage triggers ferroptosis in AML cells.
• Molecular docking suggests crotonoside inhibits mitochondrial DNA polymerase γ.
• Crotonoside modulates AML cell autophagy via the p62/KEAP1 pathway.

Conclusions:

• Crotonoside exerts its anti-AML effects by inducing mitochondrial dysfunction and ferroptosis.
• Inhibition of mitochondrial DNA polymerase γ appears to be a key mechanism.
• Crotonoside's impact on autophagy through the p62/KEAP1 pathway is linked to ferroptosis induction.
• Further research is needed to fully clarify the mechanisms of mitochondrial DNA polymerase γ inhibition and subsequent ferroptosis.